—
The recent market report released by Credence Research, Inc., the enteral syringes market was valued at US$ 528.6 million in 2018, projected to grow at a CAGR of 5.3 percent over the 2019-2027 forecast period.From 2019 to 2027, the global enteral syringes market is increasing expertly accredited to increase hospital admissions for cancer, diseases of lifestyle, malnutrition, and others. Increased approvals for new enteral syringes with upgraded tip technology from the U.S. FDA (510k clearance) will improve the worldwide market growth. Increasing partnerships, the expansion of technology and the launch of new products will contribute significant international revenue shares. By adding the new ENFit enteral syringe and accessory line for patients requiring tube feeding, Baxter International Inc. expanded its nutrition care portfolio in February 2017. Enteral syringes used primarily for the administration and nutrition of oral and enteral drugs.
Browse the full report at https://www.credenceresearch.com/report/enteral-syringes-market
Increasing NICU patients in hospitals along with admissions to hospital for pediatric or adult patients will further stimulate revenue growth for enteral syringes. Improved regulatory policies will also drive market growth in the manufacture of syringes. For example. The purpose of ENFit is to improve overall patient safety. In addition, compliant with the new standard ISO 80369-3. It supports neonate, pediatric to adult patients requiring nutrition therapy. Top corporations focused primarily on new invention and worldwide FDA 510k clearance, primarily on the U.S. market. A growing number of newborns with hospital admissions, late-stage disease patients, gastrointestinal diseases, neurology, and hypermetabolism will increase the demand for enteral syringes.
Each year, more than 100,000 newborn babies are cared for in neonatal units in the United Kingdom, primarily owing to premature birth or illness. For example, in 2016, 100,762 newborn babies received neonatal care in Scotland, England and Wales (born 25-26 weeks earlier). The U.S. industry contributed the highest income share attributed to the growing prevalence of chronic disorders, urinary disorders, end-stage renal disease, diabetes, hypertension, a huge pool of geriatrics, and the residence of biggest producers in the North American region. The key factors that drive the market growth are expanding in-home care settings for a smooth transition, increasing preference for single-use products, increasing awareness of advanced techniques and nutritional therapy procedures in developing countries globally.
Get Sample: https://www.credenceresearch.com/sample-request/59931
Report Scope by Segments:
Market Segmentation
Product Type (2017–2027; US$ Mn)
· Single Use Enteral Syringes
· Home Use Enteral Syringes
· Catheter Syringes
Application (2017–2027; US$ Mn)
· Oncology
· Malnutrition
· Neurological Disease
· GI related Disease
· Other (Diabetes, Hyper Metabolism)
Age Group Segment (2017–2027; US$ Mn)
· Neonates and Pediatric
· Adults
Key Market Movements:
• Globally, the enteral syringes is growing at a CAGR of 5.3% for the period from 2019 to 2027
• Increased general health awareness along with huge hospital admissions will drive the market growth the
Asia Pacific region owing to developments in healthcare infrastructure, rise in medical expenditure, and
medical tourism
• Increased funding by government and private organizations for better treatment options
• New product launch along with U.S FDA approval and technology expansion will drive the market growth
• Major players in this vertical are Cardinal Health Inc., Merit Medical Systems Inc., B. Braun Melsungen AG,
Baxter International, Inc., Terumo Corporation, Vygon S.A., Koninklijke Philips N.V., Retractable
Technologies Inc., Medline Industries Inc., Gerresheimer AG, Abbott Laboratories Inc., Kentec Medical, Inc., Miktell Ltd., Thermo Fischer, Inc.and others
Browse the full report at https://www.credenceresearch.com/report/enteral-syringes-market
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Release ID: 88922249